Liquidia Corporation(NASDAQ:LQDA) 
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include LIQ861, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension; ...
Website: http://www.liquidia.com
Founded: 2004
Full Time Employees: 64
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 13.63
H 14.02
L 12.78
C 12.90
V 1,900,799
10EMA 12.90
20EMA 12.90
60EMA 12.90
120EMA 12.90
250EMA 12.90